Exploring Key Insights of the Hemoglobin A1c (HbA1c) Testing Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Rapidly is the Hemoglobin A1c (HbA1c) Testing Market Expected to Expand Between 2025 and 2034 Based on Current Trends?
There has been a significant and speedy expansion in the market size of the hemoglobin a1c (HbA1c) testing in previous years. The market which was valued at $1.83 billion in 2024 is projected to soar to $2.03 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.7%. The historic period’s growth can be credited to several factors such as the escalating numbers of diabetes cases, enhanced awareness and screening programs, accelerated government initiatives and healthcare regulations, advancement in healthcare infrastructure, an increasing number of older adults, heightened diagnostic precision, and the widespread acceptance of point-of-care testing.
The market size for Hemoglobin A1c (HbA1c) testing is anticipated to witness a speedy expansion in the upcoming years, skyrocketing to $3.02 billion by 2029 with a compound annual growth rate (CAGR) of 10.5%. The significant growth within the projection period can be credited to factors such as the escalating occurrence of lifestyle-related ailments, enhanced attention towards preventive healthcare, market development in emerging nations, growth in personalized medicine and patient-driven care, regulatory backing and reimbursement policies, as well as the rise in telemedicine and distant observation. Key trends in the predicted period encompass technological progressions, amalgamation with digital health platforms, advancements in non-invasive examination technologies, telehealth expansion and remote patient tracking.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Hemoglobin A1c (HbA1c) Testing Market?
The rising cases of diabetes are anticipated to fuel the expansion of the hemoglobin A1c (HbA1c) testing market in the future. Diabetes is a long-term health problem where the body struggles to maintain blood glucose levels due to inadequate insulin production or resistance to insulin. The rise in diabetes cases can be attributed to unhealthy eating habits, primarily excessive intake of processed foods and sweet beverages, coupled with physically inactive lifestyles. Furthermore, factors like an aging population and a family history of diabetes also heighten the risk of developing diabetes. HbA1c testing is employed to track extended blood glucose control in individuals diagnosed with diabetes by assessing the average blood sugar levels over a span of the last 2–3 months. For example, data revealed by The Lancet—a UK-based book and periodic data publishing firm—in June 2023 suggests that the global diabetes cases are expected to surge from 529 million in 2021 to approximately 1.3 billion by 2050. Hence, the escalating prevalence of diabetes is likely to stimulate the growth of the hemoglobin A1c (HbA1c) testing market.
Get Your Free Sample of the Global Hemoglobin A1c (HbA1c) Testing Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=18632&type=smp
Which Key Players Are Shaping the Future of the Hemoglobin A1c (HbA1c) Testing Market?
Major companies operating in the hemoglobin A1c (HbA1c) testing market are:
• Roche Holding AG_x000D_
• Thermo Fisher Scientific Inc._x000D_
• Abbott Laboratories_x000D_
• Danaher Corporation_x000D_
• Siemens Healthineers_x000D_
How Are the Latest Trends Influencing the Growth of the Hemoglobin A1c (HbA1c) Testing Market?
Leading firms in the hemoglobin A1c (HbA1c) testing market are concentrating on advancements in diagnostic test technology, such as HbA1c home tests, to provide more accurate, convenient, and easily accessible options for early identification and management of diabetes. HbA1c home tests are at-home diagnostic kits enabling individuals to calculate their average blood glucose levels over the past 2-3 months, aiding in the monitoring and management of diabetes. For instance, Hurdle Health, a US-centric company committed to offering ground-breaking healthcare solutions, including diagnostic instruments for chronic disease management, unveiled the Hemoglobin A1c (HbA1c) Test in February 2023. This innovative at-home blood sampling test allows adults to screen and monitor diabetes, aligning with Chronomics’ objective of increasing accessibility to diagnostic tests and boosting health outcomes via direct-to-consumer solutions.
Get Instant Access to the Global Hemoglobin A1c (HbA1c) Testing Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report
Which Growth-Oriented Segments of the Hemoglobin A1c (HbA1c) Testing Market Are Leading the Industry’s Development?
The hemoglobin a1c (HbA1c) testing market covered in this report is segmented –
1) By Type: Laboratory Based Testing, Point Of Care (PoC) Testing
2) By Product Type: Instruments, Reagents, Kits
3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography, Other Technologies
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings, Other End Users
Subsegments:
1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Mass Spectrometry
2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits, Home Use Hba1c Monitoring Devices, Wireless Hba1c Testing Solutions
What Regions Are At the Forefront of Hemoglobin A1c (HbA1c) Testing Market Expansion?
North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can We Define the Hemoglobin A1c (HbA1c) Testing Market and Its Key Components?
Hemoglobin A1c (HbA1c) testing measures the percentage of hemoglobin with glucose attached, reflecting average blood glucose levels over the past 2 to 3 months. It is used to monitor long-term glucose control in diabetic patients and to diagnose diabetes and prediabetes.
Browse Through More Similar Reports By The Business Research Company:
Hematology Diagnostic Devices And Equipment Global Market Report 2024
Hemato Oncology Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report
Cardiovascular Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
